Alnylam Pharmaceuticals Inc (MEX:ALNY)
MXN 5899.69 0 (0%) Market Cap: 699.59 Bil Enterprise Value: 669.88 Bil PE Ratio: 0 PB Ratio: 1,075.42 GF Score: 78/100

Q1 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript

Apr 28, 2022 / 12:30PM GMT
Release Date Price: MXN2911.32
Operator

Good day, and thank you for standing by. Welcome to the Alnylam Pharmaceuticals First Quarter 2022 Earnings Conference Call. (Operator Instructions)

Please be advised today's conference may be recorded. (Operator Instructions)

I'd now like to hand the conference over to your host today, Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications.

Christine Regan Lindenboom
Alnylam Pharmaceuticals, Inc. - Senior VP of IR & Corporate Communications

Good morning. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam. With me today on the phone are Yvonne Greenstreet, Chief Executive Officer; Tolga Tanguler, Chief Commercial Officer; Pushkal Garg, Chief Medical Officer; and Jeff Poulton, Chief Financial Officer; Akshay Vaishnaw, President, is unable to join the call today due to a personal conflict.

For those of you participating via conference call, the accompanying slides can be accessed by going to the Events section of the Investors page

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot